Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

117.94 +3.94 (+3.46%)
Streaming Delayed Price Updated: 10:09 AM EDT, May 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Key Takeaways From iRhythm Technologies Analyst Ratings ↗
 
Via Benzinga
News headline image
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
From iRhythm
Via GlobeNewswire
News headline image
Expert Ratings For iRhythm Technologies ↗
 
Via Benzinga
News headline image
4 Analysts Assess iRhythm Technologies: What You Need To Know ↗
 
Via Benzinga
News headline image
The Analyst Verdict: iRhythm Technologies In The Eyes Of 5 Experts ↗
 
Via Benzinga
News headline image
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM)... 
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies Announces Results of GUARD-AF Trial
From iRhythm
Via GlobeNewswire
News headline image
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 4 Takes On iRhythm Technologies ↗
 
Via Benzinga
News headline image
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies to Participate in Upcoming Investor Conferences in September
From iRhythm
Via GlobeNewswire
News headline image
IRTC Stock Earnings: iRhythm Technologies Beats EPS, Beats Revenue for Q2 2024 ↗
IRTC stock results show that iRhythm Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
iRhythm Technologies Announces Chief Financial Officer Transition
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies Announces Second Quarter 2024 Financial Results
From iRhythm
Via GlobeNewswire
News headline image
7 Leading MedTech Stocks for Next-Gen Health Solutions ↗
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar. 
Via InvestorPlace
News headline image
7 Robotics Stocks That Could Grow Your Wealth ↗
Explore robotics stocks with the potential to grow investors' wealth as the industry expands across various sectors. 
Via InvestorPlace
News headline image
3 Healthcare Stocks to Buy Now: Q3 Edition ↗
U.S. healthcare expenditures will grow by 5.6% annually, presenting a revenue tailwind for these healthcare stocks to buy now. 
Via InvestorPlace
News headline image
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
From iRhythm
Via GlobeNewswire
News headline image
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio? ↗
Top performing mid-cap stocks last week: BILI (+23%), IBRX (+22%), SSL (+20%), OLLI (+15%), ITCI (+13%), AMKR (+12%), IRTC (+11%), RKLB (+11%), BFH (+10%), BRFS (+10%). 
Via Benzinga
News headline image
This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
 
Via Benzinga
News headline image
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
From iRhythm
Via GlobeNewswire
News headline image
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio? ↗
Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts. 
Via Benzinga
News headline image
J.M. SmuckerPosts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference
From iRhythm
Via GlobeNewswire
News headline image
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
IRTC Stock Earnings: iRhythm Technologies Misses EPS, Beats Revenue for Q1 2024 ↗
IRTC stock results show that iRhythm Technologies missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
iRhythm Technologies Announces First Quarter 2024 Financial Results
From iRhythm
Via GlobeNewswire
News headline image
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
From iRhythm
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.